# Definium Therapeutics, Inc. (DFTX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/dftx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company mai...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $35.67 USD |
| Market Cap | $4.79B |
| P/E (TTM) | — |
| EPS (TTM) | −$3.44 |
| 52-Week Range | $12.88 – $49.20 |
| Dividend Yield (TTM) | — |

## Dividend

DFTX has no dividend payment history in our records.

## Frequently Asked Questions

### What does Definium Therapeutics, Inc. do?

Definium Therapeutics, Inc. (DFTX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is DFTX's market cap?

Definium Therapeutics, Inc. (DFTX) has a market capitalization of approximately $4.79 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does DFTX pay a dividend?

No, Definium Therapeutics, Inc. (DFTX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is DFTX profitable?

Definium Therapeutics, Inc. (DFTX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has DFTX ever paid a dividend?

No. Dividend Data's records show no dividend payments from Definium Therapeutics, Inc. (DFTX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/dftx
- Dividend history & safety: https://www.dividenddata.com/stocks/dftx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/dftx/earnings
- Financial statements: https://www.dividenddata.com/stocks/dftx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/dftx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/dftx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.